We are live on ! Find out more
SAM

Stansberry Asset Management Portfolio holdings

AUM $973M
1-Year Est. Return 21.39%
This Fund
S&P 500
This Quarter Est. Return
+5.86%
1 Year Est. Return
+21.39%
3 Year Est. Return
+70.97%
5 Year Est. Return
+68.1%
10 Year Est. Return
AUM
$302M
AUM Growth
+$98.2M
Cap. Flow
+$88.7M
Cap. Flow %
29.38%
Top 10 Hldgs %
39.49%
Holding
107
New
37
Increased
37
Reduced
20
Closed
12

Sector Composition

Rank Sector Weight
1 Technology 16.17%
2 Financials 15.7%
3 Healthcare 11.43%
4 Real Estate 11.26%
5 Consumer Discretionary 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TBT icon
101
CALL
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$304M
-502,100
Closed -$18.2M
TBT icon
102
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$304M
-1,037
Closed -$38K
VIPS icon
103
Vipshop
VIPS
$7.37B
-31,007
Closed -$515K
JPS
104
DELISTED
Nuveen Preferred & Income Securities Fund
JPS
-11,261
Closed -$110K
ILG
105
DELISTED
ILG, Inc Common Stock
ILG
-153,871
Closed -$4.79M
MON
106
DELISTED
Monsanto Co
MON
-82,374
Closed -$9.61M
CBI
107
DELISTED
Chicago Bridge & Iron Nv
CBI
-92,462
Closed -$1.33M

Similar funds

Stansberry Asset Management's Q2 2018 Portfolio in Review

As of Q2 2018, Stansberry Asset Management held 107 positions worth $302M, up 48% from $204M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Stansberry Asset Management deployed $88.7M of net new capital in Q2 2018, opening 37 new positions and adding to 37 existing holdings. Its largest new stake was GGP Inc.: 1,064,591 shares worth $21.8M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Sarepta Therapeutics, an estimated $2.53M trimmed.

  • Stansberry Asset Management's largest Q2 2018 buy was GGP Inc.: 1,064,591 shares worth $21.8M.
  • Stansberry Asset Management added most to Dell in Q2 2018, an estimated $4.39M increase.
  • Stansberry Asset Management's biggest Q2 2018 reduction was Sarepta Therapeutics, cutting an estimated $2.53M.
  • Stansberry Asset Management fully exited Monsanto Co in Q2 2018, selling an estimated $9.61M.
  • Stansberry Asset Management's ten largest holdings make up 39% of its $302M portfolio in Q2 2018.
  • Stansberry Asset Management opened 37 new positions and closed 12 in Q2 2018.
  • Stansberry Asset Management's portfolio value rose 48% quarter-over-quarter to $302M.

Based on Stansberry Asset Management's 13F filing for Q2 2018, filed 14 Aug 2018.